FDA Says Co. Is Trying To Cash In On Meningitis Outbreak

Law360, New York (November 6, 2012, 3:00 PM EST) -- The U.S. Food and Drug Administration on Monday warned a Tennessee company to stop marketing its “LED light therapy products” as a cure for fungal meningitis, saying such claims were unproven and amounted to an attempt to cash in on an outbreak that has so far killed 30 people.

The FDA sent a warning letter to The Avalon Effect Inc. saying that the company's “Quantum Series Personal Wellness Pack” qualifies as a medical device. Because the company never applied to the FDA to market the device...
To view the full article, register now.